Clinical Trial Update: L-carnosine for Schizophrenia [NA]

View source ↗

Summary

The clinical trial database entry reports completion of a study evaluating L-carnosine for schizophrenia and schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• L-carnosine (L-carnosine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED